Objective
To test the hypothesis that quantification of mRNAs originating the second polar body (PB2) provides a non-invasive tool for assessing embryo quality.
Design
Prospective study
Setting
Hospital-based academic research laboratory
Animals
CD1 female mice
Intervention(s)
MII oocytes obtained from 7- to 8-week-old mice after pregnant mare’s serum gonadotrophin (PMSG) and human chorionic gonadotrophin (hCG) priming. After in vitro fertilization, the PB2 was biopsied from zygotes followed by reverse transcription. Real-time PCR was performed to quantify gene expression levels in single PB2. The sibling zygotes were continuously cultured to blastocyst stage.
Main Outcome Measure(s)
Embryo developmental competence and six maternal-effect gene (Dnmt1, Mater, Nobox, Npm2, Tcl1 and Zar1) transcripts in the PB2
Results
PB2 mRNA was detected in all candidate genes. Transcripts that were present in greater abundance in the zygote were more likely to be detected in qPCR replicates from single PB2. 4 candidate genes (Dnmt1, Nobox, Npm2 and Tcl1) expression levels in PB2 between two groups (2-cell embryo vs. blastocyts) approached statistical significance.
Conclusion
PB2 may contain a representative transcript profile to that of the zygote after fertilization. Differences in gene expression in PB2 may be potential biomarkers of embryo quality.